Abstract | PURPOSE: DESIGN: Interventional case series. METHODS: The medical records of 2 adult patients were reviewed. RESULTS: Both patients had a visual acuity reduced to hand motion perception bilaterally after 1 month of high-dose corticosteroid therapy, due to multiple exudative retinal detachment involving the fovea. Visual acuity and OCT findings improved immediately after the first infliximab infusion, retinal detachments fully resolved after 1 month and visual acuity returned to normal within 6 months. Despite a negative pretreatment screening, one patient developed multivisceral tuberculosis, which led to infliximab discontinuation after the 7th infusion and was cured by a 9-month ambulatory antibiotic regimen. The other patient received 11 well-tolerated infliximab infusions. Respectively, 9 and 4 months after infliximab discontinuation both patients had normal vision and OCT findings. CONCLUSION:
|
Authors | Mathieu Zmuda, Kiet Phong Tiev, Juliette Knoeri, Emmanuel Héron |
Journal | Ocular immunology and inflammation
(Ocul Immunol Inflamm)
Vol. 21
Issue 4
Pg. 310-6
(Aug 2013)
ISSN: 1744-5078 [Electronic] England |
PMID | 23617262
(Publication Type: Case Reports, Letter)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Antibodies, Monoclonal
- Tumor Necrosis Factor-alpha
- Infliximab
|
Topics |
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Antibodies, Monoclonal
(therapeutic use)
- Diagnosis, Differential
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Infliximab
- Middle Aged
- Tomography, Optical Coherence
- Treatment Outcome
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
- Uveomeningoencephalitic Syndrome
(diagnosis, drug therapy, physiopathology)
- Visual Acuity
- Young Adult
|